AHCC (active hexose correlated compound) is a natural substance extracted from certain species of basidiomycetes, a class of mushrooms that includes shiitake. AHCC is said to stimulate the immune system and increase your defence against viral infections.
AHCC may help boost immunity, according to one small clinical trial in Nutrition and Cancer. For the study, 21 healthy volunteers took either an AHCC supplement or a placebo every day for four weeks. At the study's end, members of the AHCC group showed a significantly greater increase in the number of dendritic cells—a type of cell involved in the immune response.
Immunogenics, the AHCC product BeHealthy provides supports patients with an impaired immune response, assisting with immune system surveillance and modulation.
Research into AHCC™ reveals positive effects on both innate and adaptive immunity. Specifically, AHCC™ has been shown to enhance natural killer (NK) cell activity, cytokine production, whilst promoting macrophage activity and increasing the number and activity of dendritic cells.
Furthermore, research also indicates benefits for the adaptive immune response pertaining to both B and T cell lymphocytes. AHCC™ is well tolerated, making it suitable as an adjunct for immunosuppressed patients during and in between treatments to reduce possible side effects.
Ginger assists with nausea, vomiting, gut barrier function, and also exerts anti-ulcer, anti-inflammatory and immunomodulatory effects. Supporting gastrointestinal health is paramount to optimal functioning of the immune system. Ginger provides a protective action on the intestinal mucosa and has been shown to ameliorate intestinal damage by reducing neutrophil infiltration and the pro-inflammatory response, while reducing oxidant stress and lipid peroxidation.
Ginger compounds are also able to elicit an anti-inflammatory effect via inhibition of key inflammatory response mediators, such as Nuclear factor kappa B (NFkB), Cyclooxygenase (COX) enzymes, and 5-Lipoxygenase (5-Lox).13 Furthermore, Ginger is able to support a healthy appetite thereby supporting energy production and reduce fatigue.
Having been studied in hundreds of clinical trials, AHCC™ is used in more than 600 international hospitals and institutions for an array of medical conditions. Immunogenics has been formulated to match the amount of AHCC™ used in human clinical trials. AHCC™ itself is a mixture of amino acids, lipids, and minerals extracted from a culture of Shiitake mushroom (Lentinula edodes), with polysaccharides being an active component. AHCC™ research in human populations has also shown improved immune parameters in immunocompromised people. AHCC™ has demonstrable safety and a history of being well tolerated since it’s launched in 1989, with hundreds of thousands of users reporting no serious side effects.19
AHCC™ is a registered trademark of Amino Up Chemical Co. Ltd Japan.
Research indicates the advantages of using the Immunogenics immune product with the best anti-inflammatory SPM product for inflammation in the lung.
SPM Active™ is a specific and targeted approach to facilitate the resolution phase in patients experiencing inflammation which may be failing to resolve in a timely manner. Unresolved inflammation can lead into low-grade, chronic inflammation that may worsen existing disease states, impair recovery and negatively affect healthy ageing. Chronic disease is an increasing health burden and it is now estimated that 1 in 3 Australians live with at least one chronic inflammatory condition including arthritis and other musculoskeletal disorders, cardiovascular disease and diabetes mellitus. These health issues are characterised by inflammatory processes disrupting healing and driving chronic states indicating the need for SPMs to help support healthy resolution outcomes.
SPMs found in SPM Active™ are lipid mediators that occur naturally in the body and have been found in various human tissue (such as the brain, lymph nodes and synovial fluid). SPMs orchestrate resolution at the site of inflammation to assist tissue repair, healing, recovery and the return to homeostasis. These mediators help to:
Despite omega-3 EPA and DHA being precursors of SPMs, they do not possess significant pro-resolving properties. Metagenics, in collaboration with SPMs experts and world-renowned leaders in the field of resolution physiology, are the first to set the standard for defining SPMs within a therapeutic supplement. Using a refined, patent pending fractionation process, specific SPM fractions are standardised for consistent dosing and therapeutic patient outcomes.
